IP Library Granted Patent US 10,844,109
Granted Patent B2
US 10,844,109 · App. 15/768,715 · Granted Nov 24, 2020

Method for producing erythrocyte proteins

Inventors: Isabelle Mouro-Chanteloup (Saint Cloud, FR); Sandrine Genetet (Villejuif, FR)
Assignees: Institut National Transfusion Sanguine; Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paris Diderot Paris 7
C07K14/70596C07K14/705C12P21/02G01N33/6854
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,844,109
App. No.
15/768,715
Granted
Nov 24, 2020
Kind
B2
Abstract

The invention relates to a novel method for the synthesis of an erythrocyte protein, in which said protein is synthesized in an acellular system for the production of proteins, in the presence of at least one detergent which is non-ionic, of liposomes or of nanodiscs. The invention also relates to compositions comprising the proteins produced in this way.

Claims (14)

1. A method of synthesizing an erythrocyte protein in its native form selected from RhD of SEQ ID NO: 5, RhCE of SEQ ID NO: 6, RhAG of SEQ ID NO: 7 and UTB of SEQ ID NO: 8, or a variant thereof, said method comprising the steps of:

a) contacting a nucleic acid encoding said protein or a variant having at least 95% identity therewith with an acellular protein production system, in the presence of at least one non-ionic detergent selected from Brij-35 and Brij-58, liposomes or nanodiscs; and

b) synthesizing said protein,

wherein step a) occurs either during or before step b).

2. The method according to claim 1 , wherein the contacting according to step a) occurs in the presence of nanodiscs comprising a MSP protein selected from proteins of SEQ ID NO: 9, 10 or 11.

3. The method of claim 2 , wherein said MSP protein is fused to a tag sequence.

4. The method according to claim 1 , wherein the acellular system for protein production is a batch system or an acellular system with continuous exchange.

5. The method according to claim 1 , wherein the concentration in nanodiscs is less than 80 μM.

6. The method according claim 1 , wherein said erythrocyte protein, or variant thereof is fused to a tag sequence.

7. The method of claim 1 further comprising a step of recovering the erythrocyte protein or variant thereof.

8. The method of claim 1 further comprising a step of fixing the erythrocyte protein or variant thereof to a solid support.

9. The method of claim 1 , wherein said nanodiscs comprise of one or more phospholipids selected from among dioleoylphosphocholine, dimyristoylphosphocholine, and palmitoyl oleoyl-glycero-phosphocholine.

10. The method of claim 1 , wherein said non-ionic detergent is used at a concentration comprised between 0.1% and 5%.

11. The method of claim 1 , wherein said non-ionic detergent is used at a concentration of 0.5%.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NUMBER 16930208 PREVIOUSLY RECORDED AT REEL: 060541 FRAME: 0336. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME. Recorded Jan 11, 2023
From: UNIVERSITE PARIS DESCARTES; UNIVERSITE PARIS DIDEROT - PARIS 7
To: UNIVERSITE DE PARIS
Reel/Frame 062387/0346 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NUMBER 16930208 PREVIOUSLY RECORDED AT REEL: 060390 FRAME: 0122. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jan 11, 2023
From: UNIVERSITE DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 062387/0489 →
MERGER AND CHANGE OF NAME Recorded Jun 20, 2022
From: UNIVERSITE PARIS DESCARTES; UNIVERSITE PARIS DIDEROT - PARIS 7; UNIVERSITE DE PARIS
To: UNIVERSITE DE PARIS
Reel/Frame 060541/0336 →
CHANGE OF NAME Recorded Jun 20, 2022
From: UNIVERSITE DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 060390/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2019
From: MOURO-CHANTELOUP, ISABELLE; GENETET, SANDRINE
To: INSTITUT NATIONAL TRANSFUSION SANGUINE; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); UNIVERSITE PARIS DIDEROT PARIS 7
Reel/Frame 048168/0035 →
Priority Claims (1)
FR 15 59895 · Oct 16, 2015 · national
Continuity (1)
Related Publication 20190023765A1 · Jan 24, 2019